Trial intelligence / Profile preview

OSTAP block versus laparoscopic port infiltration for analgesia in elective cholecystectomy

2020-000732-22Phase 4Active

Sponsor
Pablo Rama Maceiras
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of levobupivacaine in cholelithiasis (2 arms), sponsored by Pablo Rama Maceiras. Primary endpoint: Total morphine dose in first 4 postoperative hours. Started May 2020; status: active.

02

Drugs

levobupivacaine
03

Conditions

cholelithiasis

Beyond the preview

Go deeper on 2020-000732-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-000732-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call